Fresenius SE & Co. KGaA (FRA:FRE – Get Free Report)’s stock price traded up 1.8% on Monday. The stock traded as high as €42.73 and last traded at €42.35. 1,014,166 shares traded hands during trading, The stock had previously closed at €41.59.
Fresenius SE & Co. KGaA Price Performance
The business has a 50 day moving average of €45.34 and a 200 day moving average of €42.62.
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients.
Featured Articles
- Five stocks we like better than Fresenius SE & Co. KGaA
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
